{"id":"W2886436881","doi":"10.1159/000491387","title":"Anti VEGF-TKI Treatment and New Renal Adverse Events Not Reported in Phase III Trials","year":2018,"lang":"en","type":"article","venue":"European Thyroid Journal","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Universität Hamburg; Eisai","keywords":"Lenvatinib; Medicine; Cabozantinib; Adverse effect; Internal medicine; Axitinib; Kidney cancer; Oncology; Kidney disease; Thyroid cancer; Placebo; Gastroenterology; Cancer; Urology; Pathology; Sunitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001512615,0.0003101629,0.0008522586,0.000248099,0.0001715282,0.0000356144,0.00009334814,0.00004630991,0.0003054678],"category_scores_gemma":[0.00025682,0.0002175927,0.000254671,0.0001871856,0.00007439473,0.0001412232,0.00004797176,0.000241922,0.0001187081],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003354935,"about_ca_system_score_gemma":0.0002877951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008733703,"about_ca_topic_score_gemma":0.00003255878,"domain_scores_codex":[0.9972472,0.0004818449,0.001153558,0.0004038917,0.0003116255,0.0004018329],"domain_scores_gemma":[0.9982396,0.00008359713,0.000627689,0.0003642864,0.00009466544,0.0005901588],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02844264,0.01222184,0.1572276,0.00005585992,0.005796154,0.04398253,0.01119708,0.00003861094,0.18725,0.0002396205,0.08141105,0.472137],"study_design_scores_gemma":[0.2511073,0.02355604,0.5169629,0.001274145,0.002407728,0.01010003,0.0004646183,0.00007378666,0.03182819,0.0002129745,0.1611588,0.0008533803],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905993,0.002385655,0.00007770454,0.001579364,0.0004724325,0.0004964173,0.00001417771,0.00003930803,0.004335653],"genre_scores_gemma":[0.9907867,0.003348846,0.0005914651,0.0004416492,0.002439065,0.000006072352,0.00001823473,0.00005547889,0.002312438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4712836,"threshold_uncertainty_score":0.8873173,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09913885093718786,"score_gpt":0.3648571741514977,"score_spread":0.2657183232143099,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}